| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |